Literature DB >> 34078109

Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.

Dearbhla M Kelly1, Zanfina Ademi2, Wolfram Doehner3, Gregory Y H Lip4, Patrick Mark5, Kazunori Toyoda6, Christopher X Wong7, Mark Sarnak8, Michael Cheung9, Charles A Herzog10, Kirsten L Johansen11, Holger Reinecke12, Manish M Sood13.   

Abstract

The global health burden of chronic kidney disease is rapidly rising, and chronic kidney disease is an important risk factor for cerebrovascular disease. Proposed underlying mechanisms for this relationship include shared traditional risk factors such as hypertension and diabetes, uremia-related nontraditional risk factors, such as oxidative stress and abnormal calcium-phosphorus metabolism, and dialysis-specific factors such as cerebral hypoperfusion and changes in cardiac structure. Chronic kidney disease frequently complicates routine stroke risk prediction, diagnosis, management, and prevention. It is also associated with worse stroke severity, outcomes and a high burden of silent cerebrovascular disease, and vascular cognitive impairment. Here, we present a summary of the epidemiology, pathophysiology, diagnosis, and treatment of cerebrovascular disease in chronic kidney disease from the Kidney Disease: Improving Global Outcomes Controversies Conference on central and peripheral arterial disease with a focus on knowledge gaps, areas of controversy, and priorities for research.

Entities:  

Keywords:  atrial fibrillation; diagnosis; dialysis; epidemiology; uremia

Mesh:

Year:  2021        PMID: 34078109     DOI: 10.1161/STROKEAHA.120.029680

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Higher cystatin C level increases the risk of delayed cerebral ischemia after endovascular treatment of aneurysmal subarachnoid hemorrhage: a case-control study.

Authors:  Kehua Chen; Guanghua Huang; Chengwei Cai; Chuangnan Yan; Fuguang Zhang; Min Yao; Thanana Nuchkrua; Junqiang Ma; Hongwu Xu
Journal:  Neurosurg Rev       Date:  2022-03-05       Impact factor: 3.042

2.  Therapeutic anticoagulation complications in the elderly: a case report.

Authors:  Marcel Niemann; Karl F Braun; Sufian S Ahmad; Christian Eder; Ulrich Stöckle; Frank Graef
Journal:  BMC Geriatr       Date:  2022-02-05       Impact factor: 3.921

Review 3.  Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders.

Authors:  Dearbhla M Kelly; Peter M Rothwell
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

4.  Etiology and Outcome of Ischemic Stroke in Patients With Renal Impairment Including Chronic Kidney Disease: Japan Stroke Data Bank.

Authors:  Kaori Miwa; Masatoshi Koga; Michikazu Nakai; Sohei Yoshimura; Yusuke Sasahara; Junpei Koge; Kazutaka Sonoda; Akiko Ishigami; Yoshitaka Iwanaga; Yoshihiro Miyamoto; Shotai Kobayashi; Kazuo Minematsu; Kazunori Toyoda
Journal:  Neurology       Date:  2022-03-08       Impact factor: 11.800

5.  Lower risk of ischemic stroke among patients with chronic kidney disease using chinese herbal medicine as add-on therapy: A real-world nationwide cohort study.

Authors:  Hsuan-Shu Shen; Chung-Yi Hsu; Hei-Tung Yip; I-Hsin Lin
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

6.  Effects of chronic kidney disease on cognitive function and α-klotho expression in hippocampus.

Authors:  Menglan Huang; Guangzhi Li; Junhua Tan; Meiying Huang; Feifan Huang; Ruiying Ma; Yu Xiao; Jie Wang
Journal:  Transl Androl Urol       Date:  2022-08

7.  Deconstruction of Risk Prediction of Ischemic Cardiovascular and Cerebrovascular Diseases Based on Deep Learning.

Authors:  Yan Xu; Lingwei Meng
Journal:  Contrast Media Mol Imaging       Date:  2022-09-30       Impact factor: 3.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.